Home » Stocks » AKUS

Akouos, Inc. (AKUS)

Stock Price: $17.76 USD 0.00 (0.00%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
Market Cap 610.64M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 15.33M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $17.76
Previous Close $17.76
Change ($) 0.00
Change (%) 0.00%
Day's Open 17.51
Day's Range 17.39 - 18.47
Day's Volume 62,316
52-Week Range 17.03 - 26.92

News

There are no news available yet.

About AKUS

Akouos, a precision genetic medicine company, develops gene therapies to restore, improve, and preserve physiologic hearing for people worldwide. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate, AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. Akouos has strategic partnerships with Massachusetts Eye and Ear and Lonza, Inc. The company was founded in 2016 and is headquartered in ... [Read more...]

Industry
Biotechnology
IPO Date
Jun 26, 2020
CEO
Dr. Emmanuel Simons M.B.A., Ph.D.
Employees
54
Stock Exchange
NASDAQ
Ticker Symbol
AKUS
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for Akouos stock is "Strong Buy." The 12-month stock price forecast is 33.00, which is an increase of 85.81% from the latest price.

Price Target
$33.00
(85.81% upside)
Analyst Consensus: Strong Buy